ClinicalTrialsFinder

Early-stage Non-squamous Non-small Cell Lung Cancer (NSCLC) Clinical Trials in Suwon, Gyeonggi-do

1 recruitingSuwon, Gyeonggi-do, South Korea

Showing 1–1 of 1 trials

Recruiting
Phase 3

Pharmacokinetic Similarity Between ABP 234 and Keytruda® (Pembrolizumab)

Early-stage Non-squamous Non-small Cell Lung Cancer (NSCLC)
Amgen154 enrolled128 locationsNCT06430866